Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A gut-derived hormone regulates cholesterol metabolism
Xiaoli Hu, Fengyi Chen, Liangjie Jia, et al.
Cell (2024) Vol. 187, Iss. 7, pp. 1685-1700.e18
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Cellular Feimin enhances exercise performance by suppressing muscle thermogenesis
Ying Peng, Liangjie Jia, Hu Xiao, et al.
Nature Metabolism (2025)
Closed Access | Times Cited: 3
A feeding-induced myokine modulates glucose homeostasis
Xiaoliu Shi, Xiao Hu, Xinlei Fang, et al.
Nature Metabolism (2025)
Closed Access | Times Cited: 3
Interkingdom signaling between gastrointestinal hormones and the gut microbiome
Xinyu Zhao, Ye Qiu, Lanfan Liang, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Molecular architecture of human LYCHOS involved in lysosomal cholesterol signaling
Qi Xiong, Zhini Zhu, Tingting Li, et al.
Nature Structural & Molecular Biology (2025)
Closed Access | Times Cited: 1
Cholesin receptor signalling is active in cardiovascular system-associated adipose tissue and correlates with SGLT2i treatment in patients with diabetes
Aleksandra Ryk, Anna Marcinkiewicz, Jędrzej Chrzanowski, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Taurine alleviates dysfunction of cholesterol metabolism under hyperuricemia by inhibiting A2AR-SREBP-2/CREB/HMGCR axis
Beibei Chen, Ruixia Bao, Jujie Pan, et al.
Journal of Lipid Research (2025), pp. 100746-100746
Open Access
Advances of nanomedicine targeting the interface of cholesterol metabolism and immune evasion
Chengying Wang, Bohan Chen, Yuming Wang, et al.
Chinese Chemical Letters (2025), pp. 110921-110921
Closed Access
Cholesin mRNA Expression in Human Intestinal, Liver, and Adipose Tissues
Hannah Gilliam-Vigh, Malte P. Suppli, SEBASTIAN M. NGUYEN HEIMBÜRGER, et al.
Nutrients (2025) Vol. 17, Iss. 4, pp. 619-619
Open Access
A study into rare GPR146 gene variants in humans and mice
Boyan Zhang, Antoine Rimbert, Antoine Lainé, et al.
Atherosclerosis (2025) Vol. 403, pp. 119137-119137
Closed Access
Molecular Characteristics and Role of Buffalo SREBF2 in Triglyceride and Cholesterol Biosynthesis in Mammary Epithelial Cells
Wenbin Dao, Hongyan Chen, Yina Ouyang, et al.
Genes (2025) Vol. 16, Iss. 2, pp. 237-237
Open Access
Limosilactobacillus reuteri promotes the expression and secretion of enteroendocrine‐ and enterocyte‐derived hormones
Sara C. Di Rienzi, Heather A. Danhof, Micah D. Forshee, et al.
The FASEB Journal (2025) Vol. 39, Iss. 6
Open Access
Genome wide association study and genomic risk prediction of age related macular degeneration in Israel
Michelle Grunin, Daria Triffon, Gala Beykin, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Drugs for dyslipidaemia: the legacy effect of the Scandinavian Simvastatin Survival Study (4S)
Timo Strandberg, Petri T. Kovanen, Donald M. Lloyd‐Jones, et al.
The Lancet (2024)
Closed Access | Times Cited: 2
Probiotics as Potential Treatments for Neurodegenerative Diseases: a Review of the Evidence from in vivo to Clinical Trial
Jin Hee Kim, Yujin Choi, Seung-Min Lee, et al.
Biomolecules & Therapeutics (2024)
Open Access | Times Cited: 2
A famsin-glucagon axis mediates glucose homeostasis
A. G. Long, Yazhuo Wang, Yihua Guo, et al.
Cell Metabolism (2024)
Closed Access | Times Cited: 2
CARD8 kills CD4+ T cells in response to HIV entry
Alexandra Flemming
Nature reviews. Immunology (2024) Vol. 24, Iss. 4, pp. 232-232
Closed Access | Times Cited: 1
Inhibition of liver cholesterol synthesis by a diet-induced gut hormone
Xiabing Huang, Jianping Ye
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 10, pp. 4625-4627
Open Access | Times Cited: 1
Genetic evidence for the causal effects of air pollution on the risk of respiratory diseases
Yanjuan Wu, Yuting Zhang, Jingcun Wang, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 290, pp. 117602-117602
Closed Access | Times Cited: 1
How the body’s cholesterol factory avoids producing too much

Nature (2024) Vol. 627, Iss. 8005, pp. 707-707
Closed Access
A newly identified gut hormone suppresses cholesterol production in the liver
Irene Fernández-Ruíz
Nature Reviews Cardiology (2024) Vol. 21, Iss. 6, pp. 358-358
Closed Access
Cholesin, a new hormone bridges intestinal cholesterol absorption and hepatic synthesis
Peter Uchenna Amadi, Dawei Zhang
Life Metabolism (2024) Vol. 3, Iss. 4
Open Access
Cholesin and GPR146 in Modulating Cholesterol Biosynthesis
Jong‐Won Kim, Yu Ji Kim
Pharmacology (2024), pp. 1-7
Closed Access
Limosilactobacillus reuteri promotes the expression and secretion of enteroendocrine- and enterocyte derived hormones
Sara C. Di Rienzi, Heather A. Danhof, Micah D. Forshee, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Protocol to identify receptors of secreted proteins through CRISPR-Cas9 whole-genome screening technology
Xiaoli Hu, Yiguo Wang
STAR Protocols (2024) Vol. 5, Iss. 4, pp. 103315-103315
Open Access
Gut‑liver axis in liver disease: From basic science to clinical treatment (Review)
Jianpeng Wang, Xinyi Wang, Enba Zhuo, et al.
Molecular Medicine Reports (2024) Vol. 31, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top